Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.41M Buy
44,992
+674
+2% +$77.8K 0.05% 127
2025
Q4
$4.66M Buy
44,318
+1,445
+3% +$136K 0.05% 128
2025
Q3
$3.6M Buy
42,873
+1,313
+3% +$108K 0.04% 146
2025
Q2
$3.29M Sell
41,560
-880
-2% -$70K 0.04% 143
2025
Q1
$3.81M Buy
42,440
+16,721
+65% +$1.56M 0.04% 133
2024
Q4
$2.56M Sell
25,719
-997
-4% -$103K 0.03% 148
2024
Q3
$3.03M Sell
26,716
-9,031
-25% -$1.07M 0.04% 141
2024
Q2
$4.72M Buy
35,747
+10,179
+40% +$1.31M 0.06% 124
2024
Q1
$2.79M Sell
25,568
-780
-3% -$96.1K 0.04% 134
2023
Q4
$2.87M Buy
26,348
+327
+1% +$33.9K 0.05% 138
2023
Q3
$2.68M Buy
26,021
+1,433
+6% +$154K 0.05% 135
2023
Q2
$2.84M Sell
24,588
-4,517
-16% -$513K 0.05% 141
2023
Q1
$3.1M Buy
29,105
+1,478
+5% +$160K 0.06% 112
2022
Q4
$3.07M Buy
27,627
+924
+3% +$94.4K 0.06% 106
2022
Q3
$2.3M Buy
26,703
+7,113
+36% +$635K 0.05% 122
2022
Q2
$1.79M Buy
19,590
+8,053
+70% +$714K 0.04% 137
2022
Q1
$947K Sell
11,537
-9,865
-46% -$778K 0.02% 180
2021
Q4
$1.64M Buy
21,402
+1,517
+8% +$121K 0.03% 109
2021
Q3
$1.49M Buy
19,885
+2,877
+17% +$219K 0.04% 91
2021
Q2
$1.32M Sell
17,008
-1,008
-6% -$75K 0.03% 92
2021
Q1
$1.32M Buy
18,016
+2,650
+17% +$195K 0.04% 84
2020
Q4
$1.2M Buy
15,366
+2,138
+16% +$164K 0.04% 85
2020
Q3
$1.05M Buy
13,228
+1,238
+10% +$97K 0.04% 90
2020
Q2
$885K Buy
11,990
+7,852
+190% +$591K 0.04% 96
2020
Q1
$304K Sell
4,138
-526
-11% -$41.3K 0.02% 110
2019
Q4
$405K Buy
+4,664
New +$383K 0.03% 101

Other funds holding MRK

Mather Group's MRK Position: Q1 2026 in Review

Mather Group increased its Merck (MRK) stake by 1.5% in Q1 2026, buying an estimated $77.8K and bringing the position to 44,992 shares worth $5.41M. The position accounts for 0.05% of the portfolio, ranked #127.

Mather Group first reported a position in MRK in Q4 2019 and has held it in 26 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Mather Group held 44,992 shares of Merck worth $5.41M as of Q1 2026.
  • Mather Group bought 674 Merck shares in Q1 2026, an estimated $77.8K.
  • Merck made up 0.05% of Mather Group's portfolio in Q1 2026, its #127 holding.
  • Mather Group first reported a position in Merck in Q4 2019 and has held it in 26 quarters since.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.